DEPLOYDatabase

Company

Ultrahuman

Indian health technology company developing smart rings for continuous health monitoring (sleep, heart rate, metabolism).

Track Ultrahuman
Founded
2019
HQ
Bengaluru, India
Status
private (Series B $35M at ~$125M, Mar 2024)

Models

1

Overview

Indian health technology company developing smart rings for continuous health monitoring (sleep, heart rate, metabolism). Competing with Oura in the US market. Patent dispute with Oura. Raising $60M at $400M valuation.

Verified record

Verified deployments
None on file
Active incidents
1 incident on file

DEPLOY Intelligence

Market intelligence for physical AI

Analyst-grade signals, competitive tracking, and investment context across the global physical AI landscape. Launching 2026.

Key facts

CEO

Mohit Kumar (Co-founder & CEO — previously co-founded Runnr food delivery)

Co-founder

Vatsal Singhal (Co-founder)

HQ

Bengaluru, India

Founded

2019

Funding

Raising $60M from Steadview Capital and Blume Ventures at $400M valuation; ₹100 crore from Alteria Capital

Product

Ultrahuman smart ring — health monitoring (sleep, HR, metabolism), redesigned for US market

Oura dispute

Patent infringement case against Oura in Delhi High Court; awaiting US clearance

Incidents

None found — audited

Data & sources

Press releases

1

News coverage

1

Web sources

2

4 sources backing this record.View all →

Models (1)

View all models →

Current platform

Ultrahuman Ring (Air / Pro)

Ultrahuman, founded in 2019 in Bengaluru, India by Mohit Kumar and Vatsal Singhal, both previously of Runnr, makes the Ring Air and the newer Ring Pro biometric smart rings, recorded in the biometric form factor, on a Series B of $35 million at roughly a $125 million valuation in March 2024 with a strong India-market base and global availability. Its rings pair heart-rate, heart-rate-variability, temperature, sleep, and recovery sensing with modular PowerPlugs for metabolic and circadian insights and a paid atrial-fibrillation plug, with no mandatory subscription for core tracking. It is the load-bearing verified-versus-claimed exemplar at company-availability scope: in Oura's International Trade Commission case over patent 11,868,178, a final determination around August 22, 2025 found all asserted claims valid and infringed by Ultrahuman, issuing a limited exclusion order and cease-and-desist orders that took effect on October 21, 2025 after the sixty-day Presidential review concluded without a veto, and Ultrahuman's appeal to the Federal Circuit is pending with its emergency stay denied by both the ITC and the court, so its Ring Air's US market access was legally blocked even though the product and its AI exist and ship globally. Ultrahuman re-entered the US not via Texas-made Ring Airs but via a redesigned Ring Pro whose unibody architecture is engineered so the patent does not apply, clearing US Customs around March 24, 2026 and reopening US pre-orders, so the Ring Air is recorded as US-excluded with an appeal pending while the Ring Pro is US-available. On FDA status, its atrial-fibrillation detection is powered by the third-party FDA-cleared FibriCheck software whose vendor holds the clearance rather than Ultrahuman's ring, gated behind a paid plug, so headlines calling the ring FDA-approved overstate it, and its cumulative funding figures beyond the verified Series B and its self-published validation studies are not independently verified. A correction worth recording: the co-founder is Vatsal Singhal, not Vatsal Kumar.

biometricView model →

Ultrahuman on the deployment map

Where Ultrahuman's robots are verified operating. Explore the deployment map by place and type.

Explainers

Plain-language answers to the questions people ask about Ultrahuman, from DEPLOY’s explainer library. Each is written in the language of the question and cross-checked against this registry.

  • What is Ultrahuman Ring?

    Ultrahuman Ring (Air / Pro) is a hardware + subscription-augmented smart ring biometric, positioned within the biometric cluster's ring sub-cohort as the market-access-redesigned archetype. Co-founder Vatsal Singhal (NOT Vatsal Kumar per Agent A Wave 2 correction). KEY EDITORIAL THROUGHLINE per Agent A biometric ingest: US market access blocked October 21, 2025 via Oura ITC '178 patent ruling (final determination effective August 2025); subsequently restored March 24, 2026 via Ring Pro unibody redesign cleared US Customs. Federal Circuit appeal pending; stay denied. AFib detection routes via FibriCheck third-party app integration (NOT native FDA-cleared). Editorial throughline: within-entity verified-vs-claimed (product + AI exist globally; US market access blocked + restored via patent-redesign), parallel to Apple SpO2 feature-scope disabled-then-restored saga.

Current leadership (3)

Founders (2)

Safety record

1 incident on record (1 serious). Most recent: Oct 2025.

serious
1

Most recent: Oct 2025

Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.

Full safety record: incidents, sourcing, and exposure data →

Incidents affecting Ultrahuman (1)

Includes incidents linked directly to this company, to its models, or to deployments of its models or under its operation. Retracted incidents are excluded from this view but remain reachable at their canonical URLs.

Recent coverage

Ultrahuman in third-party press

Ultrahuman bets on redesigned smart ring to win back US market

Feb 27, 2026

Peer companies